rss
J Clin Pathol 56:271-276 doi:10.1136/jcp.56.4.271
  • Original article

There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions

Table 1

Summary of the pattern of expression of CD34 and α smooth muscle antigen (αSMA) in fibroblasts in relation to histopathological features

CD34 αSMA
Histology + +/− + +/− Total no. duct/lobular units
For normal breast, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), atypical ductal hyperplasia (ADH), and hyperplasia of usual type (HUT), figures relate to individual duct–lobular units. For fibroadenomas, radial scars, postbiopsy fibrosis, and invasive carcinomas, figures relate to case numbers.
Normal 301 0 0 0 278 23 301
HUT 88 0 0 0 79 9 88
DCIS: low 28 21 11 33 16 11 60
DCIS: intermediate 22 29 26 52 3 22 77
DCIS: high 48 311 39 362 0 36 398
LCIS 12 0 0 0 12 0 12
Invasive carcinoma 0 40 0 40 0 0 40
Microinvasion 0 6 0 6 0 0 6
Radial scar 0 21 3 5 4 15 24
Fibroadenoma 10 0 0 10 0 0 10
ADH 3 0 3 0 6 0 6
Apocrine cyst 11 0 0 0 11 0 11
Postbiopsy fibrosis 0 4 0 4 0 0 4

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest Pathology jobs

Latest Pathology jobs